Development of multiple paronychia and periungual granulation in patients treated with gefitinib, an inhibitor of epidermal growth factor receptor

被引:30
作者
Dainichi, T
Tanaka, M
Tsuruta, N
Furue, M
Noda, K
机构
[1] Hamanoumachi Hosp, Dept Dermatol, Fukuoka, Japan
[2] Hamanoumachi Hosp, Dept Internal Med, Fukuoka, Japan
[3] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Fukuoka 812, Japan
关键词
gefitinib; epidermal growth factor receptor; non-small-cell lung cancer; paronychia; periungual granulation;
D O I
10.1159/000073100
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 [皮肤病与性病学];
摘要
[No abstract available]
引用
收藏
页码:324 / 325
页数:2
相关论文
共 5 条
[1]
Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225 [J].
Busam, KJ ;
Capodieci, P ;
Motzer, R ;
Kiehn, T ;
Phelan, D ;
Halpern, AC .
BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (06) :1169-1176
[2]
PARONYCHIA AND FORMATION OF GRANULATION-TISSUE DURING ISOTRETINOIN THERAPY [J].
DERAEVE, L ;
WILLEMSEN, M ;
DECONINCK, A ;
ROSEEUW, D .
DERMATOLOGICA, 1986, 172 (05) :278-280
[3]
Selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 is generally well-tolerated and has activity in non-small-cell lung cancer and other solid tumors: Results of a phase I trial [J].
Herbst, RS ;
Maddox, AM ;
Small, EJ ;
Rothenberg, L ;
Small, EL ;
Rubin, EH ;
Baselga, J ;
Rojo, F ;
Hong, WK ;
Swaisland, H ;
Averbuch, SD ;
Ochs, J ;
LoRusso, PM .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (18) :3815-3825
[4]
THE MOUSE WAVED-2 PHENOTYPE RESULTS FROM A POINT MUTATION IN THE EGF RECEPTOR TYROSINE KINASE [J].
LUETTEKE, NC ;
PHILLIPS, HK ;
QIU, TH ;
COPELAND, NG ;
EARP, HS ;
JENKINS, NA ;
LEE, DC .
GENES & DEVELOPMENT, 1994, 8 (04) :399-413
[5]
Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor [J].
van Doorn, R ;
Kirtschig, G ;
Scheffer, E ;
Stoof, TJ ;
Giaccone, G .
BRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (03) :598-601